Notre Dame researchers found intriguing research topics Biometircs Twins

Bowyer and Flynn finding indicates that participants can correctly classify pairs of twins with 80 % accuracy using only the appearance of the iris, a level that excludes the possibility of random guessing.Every year in August, the aptly named town of Twinsburg, Ohio, is the site of the largest formal meeting of the twins in the world. Open to all multiples – identical and fraternal twins, triplets and quads from birth to octogenarians – the events of the weekend include food, live entertainment, a golf tournament, and a double block.

Their research suggests that images of the iris may be able to be used for purposes other than those under review by the research community of biometric data. The researchers plan to continue to analyze data from the event Twinsburg look more closely at the feasibility of new types of automated analysis of images of the iris. The first results of their work appear in computer vision and biometric Workshop and the International Conference on Information Technology Security Carnahan.

Bowyer and Flynn has received two grants from the Federal Bureau of Investigation for research on discrimination of identical twins. Even identical twins have unique iris. They study how the iris biometrics to confirm the first door twins argues that biometrics can differentiate between the twins and to explore whether human observers can make distinctions that current biometric iris is not possible.

A biometric is a physiological trait and the stability of a person can be measured and used to identify the person, the fingerprint is the most familiar example.

Bowyer and Flynn have developed image-based assessment and multi-biometric and biometric technologies since 2001, including the first of its kind, the comparison of photographs of the face, the face thermograms, the 3-D images of the face images of ‘iris, video of human walking, and even the ear and the forms by hand.

‘These results point to a revolutionary treatment to save the vision of people with diabetic macular edema,’ said Neil M. Bressler, MD, President and Director of the retina at the Division DRCR. ‘Eye injections of ranibizumab with rapid or delayed laser treatment must now be considered in patients with characteristics similar to those in this trial.’

In the wake of the terrorist attacks of 11 September 2001, federal agencies are increasingly interested in the feasibility and the faces of the iris recognition technology.